The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer’s disease
Beyond the core features of Alzheimer’s disease (AD) pathology, i.e. amyloid pathology, tau-related neurodegeneration and microglia response, multiple other molecular alterations and pathway dysregulations have been observed in AD. Their inter-individual variations, complex interactions and relevanc...
Main Authors: | Christopher Clark, Miriam Rabl, Loïc Dayon, Julius Popp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2022.1065904/full |
Similar Items
-
Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
by: Magdalena Mroczek, et al.
Published: (2022-03-01) -
Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people
by: Christopher Clark, et al.
Published: (2022-05-01) -
Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
by: Sami Ouanes, et al.
Published: (2022-12-01) -
Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease
by: Haitao Yu, et al.
Published: (2022-12-01) -
Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease
by: Chao Gao, et al.
Published: (2022-09-01)